HPV筛查与疫苗接种时代宫颈癌筛查利弊变化:一项模型研究
该微模拟研究基于荷兰hrHPV筛查项目,对1亿部分接种疫苗的荷兰女性估算前三轮筛查的利弊。从第一轮到第二轮,筛查检测数和CIN2+诊断数分别下降25.8%和23.6%;第三轮进一步小幅下降2.7%和5.3%。检出CIN2+的需筛查人数(NNS)总体稳定,但年轻组升高、年长组降低。
要点
- 从第一轮到第二轮,筛查检测数下降25.8%,CIN2+诊断数下降23.6%。
- 第三轮筛查检测数较前再降2.7%,CIN2+诊断数再降5.3%。
- 检出CIN2+的NNS总体稳定,但年轻年龄组升高、年长年龄组降低。
核心结论
- hrHPV筛查前几轮中利弊均下降,年轻女性效率下降,年长女性延长筛查间隔可提高效率,项目总体效率保持稳定。
研究设计与样本
- 微模拟研究,使用MISCAN模型估算筛查效果,对1亿部分接种疫苗的荷兰女性进行分析。
- 荷兰hrHPV筛查项目从30岁至65岁邀请筛查,间隔5年或10年(取决于年龄和筛查史)。
主要发现
- 筛查检测数从第一轮到第二轮下降25.8%,CIN2+诊断数下降23.6%。
- 第三轮筛查检测数较前再降2.7%,CIN2+诊断数再降5.3%。
- 检出CIN2+的NNS在各轮间保持恒定,但在年轻年龄组升高、年长年龄组降低。
临床怎么用
- 作者认为,年轻女性筛查效率将下降,而年长女性延长筛查间隔可提高效率,项目总体效率稳定,凸显低风险女性延长间隔的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To calculate the changes in harms and benefits of cervical cancer screening over the first three screening rounds of the Dutch high-risk human papillomavirus (hrHPV) screening programme. DESIGN: Microsimulation study. SETTING: Dutch hrHPV screening programme; women are invited for screening every 5 or 10 years (depending on age and screening history) from age 30 to 65. POPULATION: Partly vaccinated population of 100 million Dutch women. METHODS: Microsimulation model MISCAN was used to estimate screening effects. Sensitivity analyses were performed on test characteristics and attendance. MAIN OUTCOME MEASURES: Harms (screening tests, unnecessary referrals, treatment-related health problems), benefits (CIN2+ diagnoses) and programme efficiency (number needed to screen [NNS]) over the first (period 2017-2021), second (period 2022-2026) and third (period 2027-2031) rounds of hrHPV-based screening. RESULTS: The number of screening tests and CIN2+ diagnoses decreased from the first to the second round (-25.8% and -23.6%, respectively). In the third screening round, these numbers decreased further, albeit only slightly (-2.7% and -5.3%, respectively). NNS to detect a CIN2+ remained constant over the rounds; however, it increased in younger age groups while decreasing in older age groups. CONCLUSION: Both harms and benefits of hrHPV screening decreased over the first screening rounds. For younger women, the efficiency would decrease, whereas longer screening intervals would lead to increased efficiency in older women. Programme efficiency overall remained stable, showing the importance of longer intervals for low-risk women. TWEETABLE ABSTRACT: Cervical cancer screening: both harms and benefits of hrHPV screening will decrease in the future.
引用
- Kaljouw S, Jansen EEL, Aitken CA, et al. Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study. BJOG. 2022. PMID: 35429107. doi:10.1111/1471-0528.17190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。